BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//InvisionCommunity Events 4.7.23//EN
METHOD:PUBLISH
CALSCALE:GREGORIAN
REFRESH-INTERVAL:PT15M
X-PUBLISHED-TTL:PT15M
X-WR-CALNAME:Community Calendar
NAME:Community Calendar
BEGIN:VTIMEZONE
TZID:Europe/London
TZURL:http://tzurl.org/zoneinfo/Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T020000Z
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T020000Z
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:Webinar: Human performance in pharma manufacturing
DTSTAMP:20211005T110839Z
SEQUENCE:0
UID:582-1-ee2a5ec9cbd1b5a75b4ec5d63ec903ec@www.pslhub.org
ORGANIZER;CN="Patient-Safety-Learning":noreply@pslhub.org
DESCRIPTION:\n	Human performance in pharmaceutical and biopharmaceutical
	 manufacturing: successes and challenges to meaningful industry change\n\n
	\n\n	Adopting the principles and practices of human performance has led to
	 valuable business and safety performance improvements in high-risk high-c
	onsequence industry sectors\, such as energy and aviation. Eager to realis
	e similar levels of improvement\, several companies in the pharmaceutical 
	and biopharmaceutical manufacturing sector have begun the adoption of huma
	n performance within their operations. However\, the unique industry conte
	xt and regulatory environment of this sector has proven the adoption of hu
	man performance principles and practices to be more challenging and comple
	x than simply copying from the successes of other industries.\n\n\n\n	In t
	his webinar\, you’ll hear from industry professionals who will share the
	ir experiences and perspectives on human performance adoption value\, succ
	esses and challenges.\n\n\n\n	Register now for free\n\n\n\n	Topics and pre
	senters\n\n\n\n	Chairs\n\n	Dr Brian Edwards trained at Guy’s Hospital\, 
	London in hospital medicine and clinical research. He has worked for the M
	edicines Control Agency\, Parexel and Johnson &amp\; Johnson\, there as a 
	deputy qualified person for pharmacovigilance. For the last 13 years\, he 
	was Principal Consultant in Pharmacovigilance at NDA Regulatory Science ba
	sed in the UK. Brian is Director of ISoP Secretariat Ltd and co-chairs the
	 ISOP Medication Error Special Interest Group\, Vice President Pharmacovig
	ilance &amp\; Drug Safety in the Alliance Clinical Research Excellence and
	 Safety (ACRES) and Chair of the UK Pharmaceutical Human Factors Group. He
	 has recently been awarded a Fellowship with the International Society of 
	Pharmacovigilance. Currently he consults for his own company\, Husoteria L
	td.\n\n\n\n	Julie Avery is former Global Lead for human factors at GSK\, w
	ith over 20 years in Quality and Operational Excellence. As an independent
	 practitioner\, Julie now integrates human performance into existing syste
	ms strategically and tactically supporting business goals and KPIs. Julie 
	leads the CIEHF Human Factors Pharmaceutical Manufacturing COP and is a Tr
	ustee of the CIEHF representing Associate Members.\n\n\n\n	Topic 1: Why we
	 focus on human performance\n\n\n\n	James Morris\, executive director at N
	SF Health Sciences\, has over 30 years’ pharmaceutical operations experi
	ence in quality and manufacturing\; He’s often leading consulting and tr
	aining projects in investigation and CAPA management.\n\n\n\n	Topic 2: How
	 human performance reflects a way of thinking – beliefs and principles\n
	\n\n\n	Amy Wilson has more than 20 years’ experience in biopharma manufa
	cturing\, focusing on human and organisational performance\, operational e
	xcellence\, risk management and technical training.\n\n\n\n	John C Wilkes 
	is Human Performance lead for biologics at AstraZeneca. He has more than 2
	5 years’ experience in industry\, in manufacturing operations\, operatio
	nal excellence\, quality systems and quality control.\n\n\n\n	Topic 3: In 
	terms of internal challenges\, how can we get out of our own way?\n\n\n\n	
	Clifford Berry is head of business excellence for Takeda at its Massachuse
	tts Biologics Operations site. He’s been a human and organisational perf
	ormance practitioner for over 20 years\, with experience in commercial nuc
	lear electrical generation\, electric transmission and distribution\, and 
	biopharma.\n\n
DTSTART:20211027T160000Z
DTEND:20211027T173000Z
END:VEVENT
END:VCALENDAR
